ASENAPINE | ASENAPINE | ATC N05AH05
ANTIPSYCHOTICS 5-HT2A RECEPTOR AGONIST NERVOUS SYSTEM SCHIZOPHRENIA BIPOLAR DISORDER HIGH AFFINITY FOR SEROTONIN 5-HT1A, 5-HT1B, 5-HT2A, 5-HT2B, 5-HT2C, 5-HT5, 5-HT6, AND 5-HT7 RECEPTORS (KI VALUES OF 2.5, 4.0, 0.06, 0.16, 0.03, 1.6, 0.25, AND 0.13 NM), DOPAMINE D2, D3, D4, AND D1 RECEPTORS (KI VALUES OF 1.3, 0.42, 1.1, AND 1.4 NM), ALPHA1 AND ALPHA2-ADRENERGIC RECEPTORS (KI VALUES OF 1.2 AND 1.2 NM), AND HISTAMINE H1 RECEPTORS (KI VALUE 1.0 NM), AND MODERATE AFFINITY FOR H2 RECEPTORS (KI VALUE OF 6.2 NM) | SUBLINGUAL TRANSDERMAL | Cmax 14 NANOMOLAR (5 MILLIGRAM) F 35 PERCENT (5 MILLIGRAM) VD 1462 LITER (65 KILOGRAM) PPB 95 PERCENT Cl 52 LITER / HOUR HT 24 HOUR | 5-HT2A RECEPTOR (KI = 0.06 NANOMOLAR) D2 RECEPTOR (KI = 1.3 NANOMOLAR) | DOPAMINE D2 RECEPTOR ANTAGONIST CHEMBL217 DOPAMINE D2 RECEPTOR P14416 D(2) DOPAMINE RECEPTOR HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 SMALLMOL MONOAMINE RECEPTOR DOPAMINE RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |